5.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

102,655

116,695

 

 

受取手形及び売掛金

524,134

554,190

 

 

有価証券

38,927

24,976

 

 

商品及び製品

146,668

145,140

 

 

仕掛品

1,470

1,649

 

 

原材料及び貯蔵品

5,052

5,762

 

 

仕入割戻し等未収入金

17,647

19,892

 

 

その他

8,739

8,295

 

 

貸倒引当金

1,197

429

 

 

流動資産合計

844,099

876,172

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

153,096

155,869

 

 

 

 

減価償却累計額

87,643

90,597

 

 

 

 

建物及び構築物(純額)

65,453

65,271

 

 

 

機械装置及び運搬具

33,642

35,340

 

 

 

 

減価償却累計額

21,010

22,657

 

 

 

 

機械装置及び運搬具(純額)

12,631

12,683

 

 

 

工具、器具及び備品

19,617

20,301

 

 

 

 

減価償却累計額

16,289

16,688

 

 

 

 

工具、器具及び備品(純額)

3,328

3,612

 

 

 

土地

48,936

53,317

 

 

 

リース資産

2,959

2,949

 

 

 

 

減価償却累計額

2,398

2,406

 

 

 

 

リース資産(純額)

561

542

 

 

 

建設仮勘定

2,600

4,135

 

 

 

有形固定資産合計

133,512

139,563

 

 

無形固定資産

 

 

 

 

 

のれん

14

3,523

 

 

 

その他

12,094

12,150

 

 

 

無形固定資産合計

12,108

15,673

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

84,399

79,212

 

 

 

繰延税金資産

2,683

2,549

 

 

 

退職給付に係る資産

20,048

25,215

 

 

 

その他

17,740

18,391

 

 

 

貸倒引当金

760

1,013

 

 

 

投資その他の資産合計

124,111

124,355

 

 

固定資産合計

269,732

279,593

 

資産合計

1,113,831

1,155,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形及び買掛金

635,752

665,757

 

 

未払法人税等

9,949

10,001

 

 

賞与引当金

9,293

9,585

 

 

独占禁止法関連損失引当金

3,090

 

 

その他

21,028

27,707

 

 

流動負債合計

679,114

713,052

 

固定負債

 

 

 

 

繰延税金負債

17,413

17,915

 

 

再評価に係る繰延税金負債

1,178

1,175

 

 

退職給付に係る負債

2,186

2,142

 

 

その他

6,518

5,467

 

 

固定負債合計

27,296

26,701

 

負債合計

706,410

739,753

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

13,546

13,546

 

 

資本剰余金

32,147

32,147

 

 

利益剰余金

332,375

363,582

 

 

自己株式

499

26,344

 

 

株主資本合計

377,569

382,932

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

32,773

32,500

 

 

土地再評価差額金

4,803

4,809

 

 

為替換算調整勘定

2,365

2,736

 

 

退職給付に係る調整累計額

613

2,516

 

 

その他の包括利益累計額合計

29,722

32,944

 

非支配株主持分

128

135

 

純資産合計

407,420

416,012

負債純資産合計

1,113,831

1,155,766

 

E02780 99870 株式会社スズケン SUZUKEN CO.,LTD. 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 99870 2026-05-14 99870 2025-04-01 2026-03-31 99870 2025-04-01 2026-03-31 jppfs_cor:CapitalStockMember 99870 2025-04-01 2026-03-31 jppfs_cor:CapitalSurplusMember 99870 2025-04-01 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 99870 2025-04-01 2026-03-31 jppfs_cor:NonControllingInterestsMember 99870 2025-04-01 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 99870 2025-04-01 2026-03-31 jppfs_cor:RetainedEarningsMember 99870 2025-04-01 2026-03-31 jppfs_cor:RevaluationReserveForLandMember 99870 2025-04-01 2026-03-31 jppfs_cor:ShareholdersEquityMember 99870 2025-04-01 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 99870 2025-04-01 2026-03-31 jppfs_cor:TreasuryStockMember 99870 2025-04-01 2026-03-31 tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember 99870 2025-04-01 2026-03-31 tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember 99870 2025-04-01 2026-03-31 tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember 99870 2025-04-01 2026-03-31 tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember 99870 2025-04-01 2026-03-31 tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember 99870 2025-04-01 2026-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 99870 2025-04-01 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 99870 2025-04-01 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 99870 2026-03-31 99870 2026-03-31 jppfs_cor:CapitalStockMember 99870 2026-03-31 jppfs_cor:CapitalSurplusMember 99870 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 99870 2026-03-31 jppfs_cor:NonControllingInterestsMember 99870 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 99870 2026-03-31 jppfs_cor:RetainedEarningsMember 99870 2026-03-31 jppfs_cor:RevaluationReserveForLandMember 99870 2026-03-31 jppfs_cor:ShareholdersEquityMember 99870 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 99870 2026-03-31 jppfs_cor:TreasuryStockMember 99870 2026-03-31 tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember 99870 2026-03-31 tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember 99870 2026-03-31 tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember 99870 2026-03-31 tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember 99870 2026-03-31 tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember 99870 2026-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 99870 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 99870 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 99870 2024-04-01 2025-03-31 99870 2024-04-01 2025-03-31 jppfs_cor:CapitalStockMember 99870 2024-04-01 2025-03-31 jppfs_cor:CapitalSurplusMember 99870 2024-04-01 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 99870 2024-04-01 2025-03-31 jppfs_cor:NonControllingInterestsMember 99870 2024-04-01 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 99870 2024-04-01 2025-03-31 jppfs_cor:RetainedEarningsMember 99870 2024-04-01 2025-03-31 jppfs_cor:RevaluationReserveForLandMember 99870 2024-04-01 2025-03-31 jppfs_cor:ShareholdersEquityMember 99870 2024-04-01 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 99870 2024-04-01 2025-03-31 jppfs_cor:TreasuryStockMember 99870 2024-04-01 2025-03-31 tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember 99870 2024-04-01 2025-03-31 tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember 99870 2024-04-01 2025-03-31 tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember 99870 2024-04-01 2025-03-31 tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember 99870 2024-04-01 2025-03-31 tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember 99870 2024-04-01 2025-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 99870 2024-04-01 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 99870 2024-04-01 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 99870 2025-03-31 99870 2025-03-31 jppfs_cor:CapitalStockMember 99870 2025-03-31 jppfs_cor:CapitalSurplusMember 99870 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 99870 2025-03-31 jppfs_cor:NonControllingInterestsMember 99870 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 99870 2025-03-31 jppfs_cor:RetainedEarningsMember 99870 2025-03-31 jppfs_cor:RevaluationReserveForLandMember 99870 2025-03-31 jppfs_cor:ShareholdersEquityMember 99870 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 99870 2025-03-31 jppfs_cor:TreasuryStockMember 99870 2025-03-31 tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember 99870 2025-03-31 tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember 99870 2025-03-31 tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember 99870 2025-03-31 tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember 99870 2025-03-31 tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember 99870 2025-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 99870 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 99870 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 99870 2024-03-31 99870 2024-03-31 jppfs_cor:CapitalStockMember 99870 2024-03-31 jppfs_cor:CapitalSurplusMember 99870 2024-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 99870 2024-03-31 jppfs_cor:NonControllingInterestsMember 99870 2024-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 99870 2024-03-31 jppfs_cor:RetainedEarningsMember 99870 2024-03-31 jppfs_cor:RevaluationReserveForLandMember 99870 2024-03-31 jppfs_cor:ShareholdersEquityMember 99870 2024-03-31 jppfs_cor:TreasuryStockMember 99870 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 99870 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure